Finch (Drug Discovery) Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 191
Employees
  • Stock Symbol
  • FNCH
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $6.47
  • (As of Monday Closing)

Finch (Drug Discovery) General Information

Description

Finch Therapeutics Group Inc is a clinical-stage microbiome therapeutics company. It is leveraging Human-First Discovery platform to develop a novel class of orally administered biological drugs. It is developing novel therapeutics to deliver missing microbes and their clinically relevant biochemical functions to correct dysbiosis and the diseases that emerge from it. The lead product candidate is CP101 which delivers a complete microbiome and is being developed initially for the treatment of patients with recurrent Clostridioides difficile infection.

Contact Information

Website
www.finchtherapeutics.com
Formerly Known As
Finch Scientific, NextBiome
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 200 Inner Belt Road
  • Suite 400
  • Somerville, MA 02143
  • United States
+1 (617) 000-0000

Finch (Drug Discovery) Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Finch (Drug Discovery) Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.47 $6.60 $6.28 - $22.50 $313M 47.5M 64.5K -$1.44

Finch (Drug Discovery) Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 448,703
Revenue 19,533 7,719 10,154
EBITDA (50,372) (38,657) (20,760)
Net Income (52,196) (39,341) (20,754)
Total Assets 232,979 165,338 103,569
Total Debt 0 1,808 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Finch (Drug Discovery) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Finch (Drug Discovery)‘s full profile, request access.

Request a free trial

Finch (Drug Discovery) Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Finch (Drug Discovery)‘s full profile, request access.

Request a free trial

Finch (Drug Discovery) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Finch Therapeutics Group Inc is a clinical-stage microbiome therapeutics company. It is leveraging Human-First Discovery
Drug Discovery
Somerville, MA
191 As of 2021
00000
0000 0000-00-00
00000000 00000

000000 0

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna al
0000000000000
South San Francisco, CA
000 As of 0000
00000
00000000 00000

00000 00

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Finch (Drug Discovery) Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytomX Therapeutics Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
000000 00000000000 Venture Capital-Backed New York, NY 0 0000 00000000000 0000
0000000 0000000000 Venture Capital-Backed Cambridge, MA 000 00000 00000000000 00000
00000 00000000000 Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
You’re viewing 5 of 40 competitors. Get the full list »

Finch (Drug Discovery) Patents

  • 193

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 8

    Granted

  • 14

    Pending

  • 000

    Expiring in next 12 mo

Finch (Drug Discovery) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200281991-A1 Methods and compositions for treating disorders related to a gut dysbiosis Pending 07-Mar-2019 000000000
US-20200197449-A1 Compositions and methods for treating alopecia and related disorders Pending 19-Dec-2018 000000000
US-20200164000-A1 Compositions and methods for treating disorders related to a gut dysbiosis Pending 29-Oct-2018 000000000
CA-3114423-A1 Compositions and methods for treating epilepsy and related disorders Pending 27-Sep-2018 00000000
US-11166990-B2 Methods and compositions for treating ulcerative colitis Active 13-Jul-2018 A61K35/742 000
To view Finch (Drug Discovery)’s complete patent history, request access »

Finch (Drug Discovery) Executive Team (19)

Name Title Board Seat Contact Info
Mark Smith Ph.D Chief Executive Officer & Founder
Gregory Perry Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Greg Perry Chief Financial Officer
Marc Blaustein Chief Operating Officer, Operations
Bryan Gillis Chief Technology Officer
You’re viewing 5 of 19 executive team members. Get the full list »

Finch (Drug Discovery) Board Members (11)

Name Representing Role Since
Andrew Mulderry Finch (Drug Discovery) Board Member 000 0000
Chris Lange Shumway Capital Board Member 000 0000
Chris Shumway Self Chairman & Board Member 000 0000
Domenic Ferrante Finch (Drug Discovery) Board Member 000 0000
Jeffery Smisek JD Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Finch (Drug Discovery) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Finch (Drug Discovery) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Finch (Drug Discovery)‘s full profile, request access.

Request a free trial

Finch (Drug Discovery) Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 23-Oct-2017 0000000000 Biotechnology 0000 0000
To view Finch (Drug Discovery)’s complete acquisitions history, request access »